Metsera has brought in over $500m in funding in just seven months as it looks to enter the competitive weight loss arena.

Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with ...

Thompson CFA covers the Healthcare sector, focusing on stocks such as Travere Therapeutics, Viridian Therapeutics, and Ascendis Pharma. Currently, the analyst consensus on Spyre Therapeutics is a ...

Ascendis Pharma (ASND) is scheduled to announce Q3 earnings results on Thursday, November 14th, after market close. The ...